Linked Life Data

11307486

Source:http://linkedlifedata.com/resource/pubmed/id/11307486

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2001-4-18
pubmed:abstractText
Warfarin is highly effective in preventing thromboembolism and more recent clinical trials have established that adjusted dosing is highly effective in reducing the risk of ischemic stroke in patients with nonvalvular atrial fibrillation. Fear of major hemorrhage frequently dissuades physicians from use of anticoagulants in older people. In addition, the time needed to reach the therapeutic range may be excessively long and delicate in this population.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0755-4982
pubmed:author
pubmed:issnType
Print
pubmed:day
17
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
475-80
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
[Oral anticoagulation in older patients. Establishment and validation of a new posologic warfarin regimen].
pubmed:affiliation
Service de Gérontologie 4, Hôpital Emile Roux, Pavillon Calmette, 1, avenue de Verdun, F94456 Limeil-Brévannes. chatap.guy@wanadoo.fr
pubmed:publicationType
Journal Article, English Abstract, Validation Studies